Latest News about ENTA
Recent news which mentions ENTA
10 Biggest Price Target Changes For Monday
November 08, 2021
From Benzinga
Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’
November 05, 2021
From MarketWatch
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
November 03, 2021
From Motley Fool
What 7 Analyst Ratings Have To Say About Enanta Pharmaceuticals
October 20, 2021
Tickers
ENTA
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
October 07, 2021
From Benzinga
From Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
October 04, 2021
Tickers
ENTA
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
Tickers
ENTA
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.